Hypertrophic Cardiomyopathy Clinical Trial

A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete’s Heart

Summary

The purpose of this study is to evaluate the AI-ECG algorithm for HCM in detecting HCM and in differentiating it from athlete's heart using not only the standard 12-lead ECG, but also ECGs obtained with the Apple Watch and Alivecor KardiaMobile devices.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with clinically validated diagnoses of HCM (n=150) and athlete's heart (n=150) will be identified by pre-screening of the clinic appointments for each of the specialty HCM and Sports Cardiology clinics or in the CV fellows' clinic (in patients with an established diagnosis and no pending testing). All diagnoses will need to be supported by unequivocal imaging and other ancillary data per our standard of care and at the determination of clinic experts.

Exclusion Criteria:

Any exception to the above criteria.

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

300

Study ID:

NCT06290570

Recruitment Status:

Not yet recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic in Rochester
Rochester Minnesota, 55905, United States More Info
Heart Rhythm Services Research Team
Contact
507-255-0774
Konstantinos Siontis, MD
Contact
(507) 255-1051
[email protected]
Konstantinos Siontis, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

300

Study ID:

NCT06290570

Recruitment Status:

Not yet recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.